New Findings on Prostate Cancer Described by Investigators at University of California San Francisco (UCSF) (Early Endpoints In High-risk Localized Prostate Cancer: Exploratory Analysis of Three Radiation Therapy Oncology Group Phase 3 Studies).
In: Cancer Weekly, 2023-10-17, S. 563-563
serialPeriodical
Zugriff:
Keywords: San Francisco; State:California; United States; North and Central America; Cancer; Clinical Research; Clinical Trials and Studies; Drugs and Therapies; Enzymes and Coenzymes; Health and Medicine; Oncology; Pharmaceuticals; Prostate Cancer; Prostate-Specific Antigen; Prostatic Neoplasms; Radiation Therapy; Risk and Prevention EN San Francisco State:California United States North and Central America Cancer Clinical Research Clinical Trials and Studies Drugs and Therapies Enzymes and Coenzymes Health and Medicine Oncology Pharmaceuticals Prostate Cancer Prostate-Specific Antigen Prostatic Neoplasms Radiation Therapy Risk and Prevention 563 563 1 10/16/23 20231017 NES 231017 2023 OCT 17 (NewsRx) -- By a News Reporter-Staff News Editor at Cancer Weekly -- Research findings on Oncology - Prostate Cancer are discussed in a new report. PSA-R was defined as PSA nadir + 2 ng/ml; PSA nadir + 2 ng/ml and rising; PSA >5, 10, and 25 ng/ml; or PSA doubling time (PSADT) <6 mo. [Extracted from the article]
Copyright of Cancer Weekly is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
New Findings on Prostate Cancer Described by Investigators at University of California San Francisco (UCSF) (Early Endpoints In High-risk Localized Prostate Cancer: Exploratory Analysis of Three Radiation Therapy Oncology Group Phase 3 Studies).
|
---|---|
Zeitschrift: | Cancer Weekly, 2023-10-17, S. 563-563 |
Veröffentlichung: | 2023 |
Medientyp: | serialPeriodical |
ISSN: | 1071-7218 (print) |
Sonstiges: |
|